Roche Cardiac Solutions
When a patient presents with
heart failure, will you know EVERY medication they’re taking?

Some biomarkers are affected by certain medications.
For instance, if a patient is taking an ARNI (angiotensin
receptor-neprilysin inhibitor), BNP levels will appear
elevated, potentially leading to erroneous treatment.
Using NT-proBNP, levels of which are not affected
by neprilysin, you can ensure you will have
the most accurate clinical picture to provide the best
patient care.1

NT-proBNP levels are not affected by neprilysin

1. Packer M, et al. Circulation. 2015;131(1):54-61.

NT-proBNP May Offer a Distinct Advantage in the Detection of Stage A and B Heart Failure1

NT-proBNP has the analytical advantage over BNP

NT-proBNP can aid physicians in determining the optimal treatment for patients with heart failure.2

Analytical Advantages Provide Diagnostic Confidence

1. Emdin M. Clin Chem. 2007;53:71289-71297.
2. Weber M, et al. Circulation. 2006;92:843-849.
3. Bettencourt P. Circulation. 2004;110(15):2168-2174.